AGI Greenpac Ltd Q4 FY26 Earnings Analysis

- The company expects volume growth of 8%-10% for the next 12-18 months, supported by minor expansions in specialty and container glass capacities. - For FY27, overall volume growth is projected around 8%-9%, with specialty glass showing higher efficiency and growth. - A new Greenfield container glass plant (500 tons/day) scheduled for commissioning by March 2027 will add ~25% capacity, driving 15%-17% growth in FY27-28. - Commercial container glass volume growth expected around 3%-4% in FY27, and specialty glass around 7% or higher. - Volumes in Q3 were subdued due to weather and seasonal factors, especially in beer segment, but are expected to normalize and recover in Q4. - Long-term growth is aided by capacity additions, product portfolio diversification, and stable demand from pharmaceutical, cosmetic, and premium beverage segments. - Revenue growth is volume-driven, but value growth may be affected by raw material price volatility.

- AGI Greenpac expects 8%-10% volume growth in the next 12-18 months, maintaining EBITDA margins of 24%-25%. - For FY27, volume growth is projected around 7%-9%, driven by minor debottlenecking and 3%-4% container glass growth. - FY27-28 will see 15%-17% growth due to incremental capacity from a new Greenfield plant adding ~25% capacity. - Specialty glass EBITDA margins expected to stay stable around 25%-26%. - EBITDA per ton guidance is Rs.9,500 to Rs.10,500 excluding non-operating income. - Long-term EBITDA and margins expected to remain steady, with continued focus on premium and specialty segments. - New capacities and operational optimizations are anticipated to drive incremental EBITDA and cash flows. - Management is open to equity or debt funding to support growth but aims to create long-term stakeholder value.

- Completed CAPEX of around Rs.220 crores in the nine months ended December 2025, primarily on expanding and optimizing glass business lines. - Additional CAPEX of Rs.20-30 crores expected in Q4 FY26, mainly for specialty glass line de-bottlenecking. - Large-scale CAPEX of Rs.1,100 to Rs.1,200 crores planned for FY27 with shareholder-approved fund-raising resolution in place. - Greenfield container glass facility in Madhya Pradesh underway, aimed at commissioning by March 2027, adding 500 tons per day capacity (approx. 25% capacity increase). - Strategic entry into aluminum beverage can segment progressing, with equipment procurement in final stages for 1.6 billion cans annual capacity. - Focus on internal accrual financing for CAPEX, but open to equity raise depending on market conditions. - The company aims to use these investments to sustain volume growth, improve operational efficiency, and expand premium products portfolio.

- The company has shareholder approval to conduct a Qualified Institutional Placement (QIP) but has not decided to close such a transaction yet. - Equity raising may be needed depending on project maturity, free cash flows, market price, and timing. - Management is mindful of shareholder concerns about dilution and aims to create value for all stakeholders. - Debt funding is currently being tied up to complete large-capex projects with plans to reduce existing debt over time. - Net debt is manageable with an expected EBITDA-to-debt ratio near 2x even if equity is not raised immediately. - The company is open to investor feedback on potential rights issues but will decide at the appropriate time. - Overall, fundraising plans (equity or debt) will be actioned based on market conditions, project progress, and growth acceleration needs.

- The transcript provided does not explicitly mention the current or expected order book or pending orders for AGI Greenpac Limited. - However, it indicates strong demand and operational efficiency, with container glass plants operating at approximately 95% utilization. - Specialty glass capacity is at around 85% utilization, reflecting healthy demand. - Volume growth is expected around 8%-10%, with incremental capacity additions (25% increase) scheduled by March 2027. - The company mentioned a healthy ramp-up and steady demand for high-margin segments such as pharmaceutical, cosmetic, and premium beverages. - Temporary subdued demand in some segments like beer due to weather, expected to normalize soon. - Overall, demand trends suggest a robust order flow supporting capacity utilization and planned expansions.